Industry News
Immuron to issue $4.1m worth of options
Immuron (ASX:IMC) plans to issue $4.1m worth of options exercisable at $0.04 per share - just under twice the current trading price of the company's shares. [ + ]
Slideshow: Genetically modified flowers glow in the dark
Adelaide-based Bioconst has begun developing a line of genetically modified fluorescent flowers that produce a protein that glow when exposed to a proprietary UV LED. [ + ]
Feature: Moving target
Professor Johnson Mak is working to understand how HIV functions with the hope of revealing weaknesses that could enable effective treatments and vaccines. [ + ]
CSIRO signs landmark agreement with US NOAA on marine and climate research
CSIRO and the United States’ National Oceanic and Atmospheric Administration (NOAA) today signed a series of agreements that bring together the scientific capabilities of two global leaders in marine and atmospheric research. [ + ]
Climate change causing leaves of some Australian plants to narrow
University of Adelaide researchers have discovered that recent climate change is causing the leaves of some Australian plants to narrow in size. [ + ]
Australians and the global IP protest
Concern is growing in Australia about attempts by various governments to introduce stronger intellectual property (IP) right enforcement standards. In a major vote on Wednesday night, the European parliament rejected the new Anti-Counterfeiting Trade Agreement (ACTA). [ + ]
Latest AusBiotech journal features special investment edition
AusBiotech is pleased to announce that the July edition of AusBiotech’s journal, Australasian Biotechnology, is now published, featuring a special investment edition. [ + ]
Cancer Therapeutics proves concept behind new drug
Cancer Therapeutics has revealed positive preclinical results from a trial of CTx-294886 and that it has produced a new small molecule screening platform. [ + ]
TGA fee hike under fire from industry
Several biotech and pharmaceutical industry associations have banded together to call for the recent TGA fee hike to be wound back. [ + ]
‘God particle’ collides with art and society this Sunday
Last night’s announcement of the discovery of the Higgs boson, or ‘God particle’, will collide with art and society on Sunday 8 July. ‘Colliding Ideas: Art, Society and Physics’ is a free public symposium, to be held at RMIT University in Central Melbourne from noon-5 pm. [ + ]
CERN experiments observe particle consistent with long-sought Higgs boson
At a seminar held at CERN yesterday as a curtain raiser to the year’s major particle physics conference, ICHEP2012 in Melbourne, ATLAS and CMS experiments presented their latest preliminary results in the search for the long-sought Higgs particle. [ + ]
Sirtex sales defy global economic woes
Sirtex Medical (ASX:SRX) recorded strong quarterly and full-year growth for dose sales of its SIR-Spheres targeted radioactive liver cancer treatments. [ + ]
Starpharma accelerates dendrimer program
Starpharma (ASX:SPL) is researching expanding its dendrimer nanotechnology platform to a wide range of drug classes besides its initial focus on chemotherapeutics. [ + ]
QRxPharma may face more trials for MoxDuo
QRxPharma will meet with the FDA in August to discuss whether more trials of MoxDuo IR are required or existing data reanalysed, but CEO John Holaday is confident its application is “more than adequate for approval”. [ + ]
Biomedical and plant sciences the winner with new appointment
Professor Ryan Lister, an expert in the use of advanced DNA sequencing technologies and computational biology to understand how complex biological systems work, has been appointed to The University of Western Australia (UWA). [ + ]